Beijing Biomarker

Beijing Biomarker Biotechnology Co., Ltd. was established in Beijing Konggang Industrial Park in May 2009, with over 60% of employees holding master's or doctoral degrees and over 30% holding bachelor's degrees. The company comprises three business divisions: the Medical Division, the Cloud Platform Division, and the Technology Service Division:
1) The Medical Division is dedicated to deciphering the genetic code, safeguarding human health, and providing professional, refined, and high-quality "personalized medicine" for patients and doctors. Its main areas include prenatal screening, detection of single-gene genetic diseases, personalized cancer treatment, and risk gene testing and treatment planning for diseases such as breast cancer. Products include Baibeikang, Airukang, Jian yikang, Baibeian, and Aijiankang.
2) The Cloud Platform Division is committed to building a web-based bioinformatics big data visual analysis platform integrating private cloud, public cloud, and training. Currently, 7 standard APP analysis processes and nearly 200 analysis tools have been deployed for commercial application.
3) The Technology Service Division is dedicated to providing researchers with optimal, comprehensive, and professional services based on high-throughput sequencing technology and bioinformatics technology.
Since its inception, the company has adhered to the corporate mission of "biotechnology innovation, serving society, and benefiting the people," and is committed to the development vision of "building a biotechnology innovation center and establishing a benchmark enterprise in the bio-industry" to improve human quality of life faster and better through biotechnology. With internationally advanced high-throughput sequencing platforms and high-performance computing platforms, as well as an independent innovation production and R&D team mainly composed of master's and doctoral degree holders, the company has achieved fruitful results in core businesses such as biotechnology services, bio-cloud platforms, and medical testing. It has published multiple papers in academic journals such as Nature Communications, obtained 3 technical invention patents, and filed for over ten patents and nearly a hundred software copyrights. After years of development, its business covers more than 30 provinces, municipalities, and autonomous regions across the country. Biomarker has maintained a growth rate of over 100% for multiple business indicators for several consecutive years. The company has been honored with awards such as "Deloitte Technology Fast 500 Asia Pacific," "Beijing Postdoctoral (Young Talent) Innovation Practice Base," "National High-tech Enterprise," "Zhongguancun High-tech Enterprise," and "2015 Zhongguancun High Growth TOP 100 Enterprise."
Biomarker enjoys a convenient geographical location: 900 meters from the subway, 50 meters from bus stops, and a 30-minute commute to downtown Beijing. It is also away from the city center, offering better air quality and environment. The company provides favorable conditions for employees in terms of salary, vacation, and holiday benefits, and effectively addresses various difficulties for employees. Outstanding employees are processed for high-level talent introduction in accordance with Beijing municipal policies.
The 21st century is the century of biology. Biomarker firmly believes that the bio-industry is the most promising industry in the 21st century and has been making unremitting efforts toward this goal. We are confident that with the guidance and support of leaders and experts from all walks of life, and through the joint efforts of all Biomarker colleagues, our vision of "building a biotechnology innovation center and establishing a benchmark enterprise in the bio-industry" will surely be realized.